Commenting on the study, Anne Davidson, MBBS, chair of the Rheumatology Research Foundation, an investigator at the Feinstein Institute for Medical Research, and professor of molecular medicine at Hofstra North Shore-LIJ School of Medicine in Manhasset, N.Y., emphasized the wide disparities in the quality of RA treatment among Medicare managed care organizations found in the study. “This is the first step to finding ways to improve patient care among large patient cohorts,” she said.
Mary Beth Nierengarten is a freelance medical journalist in St. Paul, Minn.
ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE